Bexarotene: a clinical review (Q35728639)

9 August 2017

1 reference

title

Bexarotene: a clinical review (English)

1 reference

9 August 2017

Len T Farol

1

1 reference

PubMed ID

15056048

9 August 2017

Kenneth B Hymes

series ordinal

2

1 reference

9 August 2017

1 April 2004

1 reference

Expert Review of Anticancer Therapy

9 August 2017

1 reference

9 August 2017

4

1 reference

9 August 2017

2

1 reference

9 August 2017

180-188

1 reference

Embryonic retinoic acid synthesis is essential for early mouse post-implantation development

9 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.2.180

Retinoid-induced apoptosis in normal and neoplastic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.2.180

A new class of retinoids with selective inhibition of AP-1 inhibits proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.2.180

The biology of acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.2.180

Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.2.180

A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.2.180

Keratinocyte differentiation in hyperproliferative epidermis: topical application of PPARalpha activators restores tissue homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.2.180

Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.2.180

Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.2.180

Bexarotene capsules and gel for previously treated patients with cutaneous T-cell lymphoma: results of the Australian patients treated on phase II trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.2.180

Topical targretin and intralesional interferon alfa for cutaneous lymphoma of the scalp

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.2.180

Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.2.180

21 January 2018

Identifiers

DOI

10.1586/14737140.4.2.180

1 reference

9 August 2017

1 reference

PubMed ID

15056048